- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Blue chip stocks
U.S. Pharmaceuticals & Biotech Blue chip stocks
UPDATED Jun 26, 2024
17 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ILMN | US$105.68 | -2.2% | -42.7% | US$17.5b | US$148.25 | PS3.7x | E45.6% | n/a | ||
RVTY | US$104.32 | -2.8% | -11.0% | US$12.9b | US$124.10 | PE70.2x | E26.2% | 0.3% | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
VTRS | US$10.43 | 3.8% | 7.3% | US$12.3b | US$12.40 | PB0.6x | E5.2% | 4.6% | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | ||
BGNE | US$146.44 | -5.3% | -18.6% | US$16.0b | US$267.01 | PS5.6x | E60.7% | n/a | ||
MRK | US$131.50 | 2.7% | 17.0% | US$336.7b | US$142.68 | PE144.4x | E23.7% | 2.3% | ||
SRPT | US$156.91 | 33.5% | 40.2% | US$14.9b | US$197.81 | PE877.8x | E39.4% | n/a | ||
ABBV | US$171.15 | -0.1% | 29.2% | US$301.5b | US$183.24 | PE50.8x | E21.9% | 3.6% | ||
GILD | US$69.31 | 9.8% | -9.0% | US$86.7b | US$82.97 | PE178x | E36.2% | 4.4% | ||
PFE | US$27.42 | 0.04% | -24.4% | US$158.6b | US$31.92 | PS2.8x | E30.6% | 6.1% | ||
MEDP | US$405.33 | 0.6% | 76.9% | US$12.6b | US$429.04 | PE40.1x | E14.9% | n/a | ||
BMY | US$42.50 | 4.1% | -33.7% | US$85.5b | US$53.19 | PS1.9x | E44.7% | 5.6% | ||
BMRN | US$85.25 | 1.3% | -7.6% | US$16.1b | US$108.09 | PE78.8x | E30.1% | n/a | ||
NBIX | US$135.83 | 3.8% | 43.3% | US$13.6b | US$160.54 | PE37x | E27.1% | n/a | ||
INCY | US$61.75 | 0.5% | 1.3% | US$14.2b | US$72.80 | PE18.6x | E17.3% | n/a | ||
VRTX | US$474.00 | 1.4% | 35.1% | US$122.3b | US$465.53 | PE30.4x | E10.4% | n/a |
Page 1 of 1